Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2003
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175248 Comprises thrombocyte-rich plasm and calcium phosphates for use in skin and bone defects
09/18/2003CA2478942A1 An optically active pyridine derivative and a medicament containing the same
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/18/2003CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2478599A1 Salts of nateglinide
09/18/2003CA2478522A1 Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
09/18/2003CA2478317A1 Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
09/18/2003CA2478245A1 Treatment and prevention of inflammatory disorders
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003CA2477701A1 Controlled release dosage forms
09/18/2003CA2476031A1 Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343818A1 Modified tachykinin receptors
09/17/2003EP1343789A1 Tricyclic derivatives of indole with antiangiogenic activity
09/17/2003EP1343786A1 Novel pyridine-substituted pyrazolopyridine derivatives
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343779A2 Novel compounds
09/17/2003EP1343774A1 1,1-dioxo-2h-1, 2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compositions comprising same
09/17/2003EP1343769A1 Benzoylpyridazines
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343513A1 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
09/17/2003EP1343511A1 Shark meat extract
09/17/2003EP1343509A2 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
09/17/2003EP1343508A1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343488A1 Treatment of statin side effects
09/17/2003EP1343487A2 Methods and compositions to treat conditions associated with neovascularization
09/17/2003EP1343485A2 Lipid-based nitric oxide donors
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1169056B1 Caspase-8 inhibitors for immunosuppression.
09/17/2003EP1147119B1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP1100471B1 Compressed compositions comprising clarified xanthan gum
09/17/2003EP1095021B1 Quinoline derivatives
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
09/17/2003CN1443199A Antibodies to human MCP-1
09/17/2003CN1443190A Matrix metalloproteinase inhibitors
09/17/2003CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443170A Capsaicin receptor ligands
09/17/2003CN1443168A 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
09/17/2003CN1443073A Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof
09/17/2003CN1443065A Pharmaceutical composition improved in peroral absorbability
09/17/2003CN1442201A Compound containing osteoclast formation inhibiting factor and polysaccharide
09/17/2003CN1442179A Medicine used for joining bone
09/17/2003CN1442178A Rheumatoid disease health recovery admixture
09/17/2003CN1442177A Health care wine for women
09/17/2003CN1442157A Medicine for treating rheumatic and rheumatoid disease and its preparation method
09/17/2003CN1442152A Bony spur eczema ointment
09/17/2003CN1442139A Medicinal composition for treating inflammation
09/17/2003CN1121385C Haphthyl compounds, intermediates, compositions and methods of use
09/17/2003CN1121236C Medicine for curing rheumatoid arthritis and preparing method
09/17/2003CN1121235C Medicine for treating osteoporosis and its preparing process
09/16/2003US6620919 Lipoxin compounds and their use in treating cell proliferative disorders
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620851 Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen
09/16/2003US6620842 Chalcones
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620829 Administering a therapeutically effective amount of a GABA analog having characteristic of being an inhibitor of cartilage damage, or a pharmaceutically acceptable salt
09/16/2003US6620784 Uses of VEGF-E
09/16/2003US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or
09/16/2003US6620427 Administering calcium compoound and fat blend
09/16/2003US6620423 Ropivacaine for use as an analgesic in the treatment of muskuloskeletal pain
09/16/2003CA2294090C Method and product using sturgeon notochord for alleviating the symptoms of arthritis
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2105683C N-¬¬4,5-dihydroxy-and 4,5,8-trihydroxy-9,10-dihydro-9, 10-dioxo-2-anthracene-yl|carbonyl|amino acids useful in the therapy of osteoarticular affections
09/12/2003WO2003074711A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003WO2003074525A1 Nitrogen-containing heterocyclic compound
09/12/2003WO2003074512A1 Isoquinoline derivatives
09/12/2003WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074098A1 Modified phosphocalcic compound, injectable composition containing same
09/12/2003WO2003074084A1 A pharmaceutical composition
09/12/2003WO2003074080A1 Treatment of central nervous system damage
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074048A1 Method of treating osteoarthritis
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073991A2 Methods to increase or decrease bone density
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073982A2 Anti-interleukin-1 beta analogs
09/12/2003WO2003051828A3 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003041684A3 Injectable depot compositions and uses thereof
09/12/2003WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity
09/12/2003WO2003034995A3 Integrin targeting compounds
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003WO2002028424A9 Kyberdrug as autovaccines with immune-regulating effects
1 ... 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 ... 820